At OG+S, gratitude isn’t just a buzzword; it’s a cornerstone of our culture. As a staff member in this unicorn law firm—where innovation meets unwavering commitment to our clients—I find myself constantly thankful to be part of a workplace that truly values team collaboration and individual contributions.
Every day, I experience the synergy that comes
There are four pending BPCIA litigations brought by Amgen against biosimilar companies seeking to market denosumab biosimilars. Two of the four cases are pending in the District Court for the District of New Jersey before Judge O’Hearn: Amgen Inc. et al. v. Celltrion, Inc., No. 1:24-cv-06497-CPO-EAP (D.N.J.), filed on May 28, 2024, and Amgen Inc.
We’re proud to share that Seyfarth has been named “Highly Recommended” in World Intellectual Property Review’s inaugural 2024 USA Trade Secrets Rankings. This guide highlights the top law firms and lawyers leading the way in trade secrets law across the United States.
This recognition reflects the hard work and dedication of our team as we
Weintraub Tobin is pleased to announce that its acclaimed entertainment, media, and intellectual property podcast series The Briefing has reached 200 episodes. Set to air on November 27, 2024, the milestone 200th episode reflects four years of discussions on the legal intersection of creativity, innovation, and IP law.
NPEs continued an active start to the year in February.* Frequent filers Analytical Technologies, Advanced Transactions, Communication Interface Technologies, Consolidated Transaction Processing, Linfo IP, S3G Technology, Symbology and Virtual Creative Artists.
As usual, I prepared the report in partnership with and using Docket Navigator and its powerful database. Docket Navigator is a valuable resource, and
What are the benefits of a trademark attorney? Securing a trademark is a critical step in building and protecting your brand. While it may seem straightforward, the process can be surprisingly complex. That’s where a trademark attorney comes in. These legal professionals specialize in trademark law and offer significant advantages that can save you time,
The recent Full Federal Court decision in Zoetis Services LLC v Boehringer Ingelheim Animal Health USA Inc [2024] FCAFC 145 has highlighted fundamental flaws in the Australian patent law’s ‘best method’ requirement. While the court’s application of existing principles appears sound, the resulting analysis reveals that the requirement is not only arbitrary in its operation,
IPNews® – A battle is brewing between the U.S. Marine Corps and the National Collegiate Athletic Association (NCAA).
The Marine Corps is seeking trademark rights to MARCH MANIA. This isn’t OK with the NCAA, which has long standing rights to MARCH MADNESS. To continue reading, click: NCAA Takes on the Marines Over March Madness Trademark
A recent Full Court decision suggests that demonstrating prior art could be ‘reasonably expected to be ascertained’ under the pre-Raising the Bar (RtB) law may be considerably easier than previously thought. But has the pendulum swung too far? In relaxing the evidentiary requirements for establishing that prior art information would have been found by the
On November 18, 2024, Samsung Bioepis announced that the European Commission (EC) has approved its aflibercept biosimilar, OPUVIZ. Referencing Regeneron’s biosimilar product EYLEA, OPUVIZ is a 40 mg/mL solution for injection, approved for the treatment of neovascular age related macular degeneration, visual impairment due to macular oedema secondary to retinal vein occlusion, visual impairment due
